422 related articles for article (PubMed ID: 23049525)
1. Animal models on HTLV-1 and related viruses: what did we learn?
Hajj HE; Nasr R; Kfoury Y; Dassouki Z; Nasser R; Kchour G; Hermine O; de Thé H; Bazarbachi A
Front Microbiol; 2012; 3():333. PubMed ID: 23049525
[TBL] [Abstract][Full Text] [Related]
2. HTLV-1 Infection and Pathogenesis: New Insights from Cellular and Animal Models.
Forlani G; Shallak M; Accolla RS; Romanelli MG
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360767
[TBL] [Abstract][Full Text] [Related]
3. Molecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus Type-1 (HTLV-1).
Johnson JM; Harrod R; Franchini G
Int J Exp Pathol; 2001 Jun; 82(3):135-47. PubMed ID: 11488989
[TBL] [Abstract][Full Text] [Related]
4. Pentosan Polysulfate Demonstrates Anti-human T-Cell Leukemia Virus Type 1 Activities
Ma G; Yasunaga JI; Ohshima K; Matsumoto T; Matsuoka M
J Virol; 2019 Aug; 93(16):. PubMed ID: 31167921
[TBL] [Abstract][Full Text] [Related]
5. Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL.
Kannagi M; Hasegawa A; Nagano Y; Kimpara S; Suehiro Y
Retrovirology; 2019 Aug; 16(1):23. PubMed ID: 31438973
[TBL] [Abstract][Full Text] [Related]
6. Mouse models of human T lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma.
Zimmerman B; Niewiesk S; Lairmore MD
Vet Pathol; 2010 Jul; 47(4):677-89. PubMed ID: 20442421
[TBL] [Abstract][Full Text] [Related]
7. Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis.
Nozuma S; Kubota R; Jacobson S
J Neurovirol; 2020 Oct; 26(5):652-663. PubMed ID: 32705480
[TBL] [Abstract][Full Text] [Related]
8. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
Gessain A; Mahieux R
Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
[TBL] [Abstract][Full Text] [Related]
9. Essential Role of Human T Cell Leukemia Virus Type 1
Galli V; Nixon CC; Strbo N; Artesi M; de Castro-Amarante MF; McKinnon K; Fujikawa D; Omsland M; Washington-Parks R; Romero L; Caruso B; Durkin K; Brown S; Karim B; Vaccari M; Jacobson S; Zack JA; Van den Broeke A; Pise-Masison C; Franchini G
J Virol; 2019 Oct; 93(19):. PubMed ID: 31315992
[TBL] [Abstract][Full Text] [Related]
10. Human T-cell lymphotropic virus type-I infection in the severe combined immunodeficiency mouse.
Furlan R; Salazar-Grueso EF; Martino G; Roos RP; Brambilla E; Castellano M; Cao J; Lillo F; Terreni MR; Bacellar H; Dorigatti F; Grimaldi LM
J Med Virol; 1996 Jun; 49(2):77-82. PubMed ID: 8991939
[TBL] [Abstract][Full Text] [Related]
11. Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma.
Giusti RM; Maloney EM; Hanchard B; Morgan OS; Steinberg SM; Wachter H; Williams E; Cranston B; Fuchs D; Manns A
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):699-704. PubMed ID: 8877061
[TBL] [Abstract][Full Text] [Related]
12. Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation.
Lairmore MD; Silverman L; Ratner L
Oncogene; 2005 Sep; 24(39):6005-15. PubMed ID: 16155607
[TBL] [Abstract][Full Text] [Related]
13. Modulation of innate immune responses during human T-cell leukemia virus (HTLV-1) pathogenesis.
Olière S; Douville R; Sze A; Belgnaoui SM; Hiscott J
Cytokine Growth Factor Rev; 2011 Aug; 22(4):197-210. PubMed ID: 21924945
[TBL] [Abstract][Full Text] [Related]
14. Manifestations of the human T-cell lymphotropic virus type I infection in childhood and adolescence.
Bittencourt AL; Primo J; Oliveira MF
J Pediatr (Rio J); 2006; 82(6):411-20. PubMed ID: 17171202
[TBL] [Abstract][Full Text] [Related]
15. Implications of the evolution pattern of human T-cell leukemia retroviruses on their pathogenic virulence (Review).
Azran I; Schavinsky-Khrapunsky Y; Priel E; Huleihel M; Aboud M
Int J Mol Med; 2004 Nov; 14(5):909-15. PubMed ID: 15492865
[TBL] [Abstract][Full Text] [Related]
16. [Epidemiology, origin and genetic diversity of HTLV-1 retrovirus and STLV-1 simian affiliated retrovirus].
Gessain A; Mahieux R
Bull Soc Pathol Exot; 2000 Jul; 93(3):163-71. PubMed ID: 11030050
[TBL] [Abstract][Full Text] [Related]
17. Human T cell leukemia virus type I-induced disease: pathways to cancer and neurodegeneration.
Barmak K; Harhaj E; Grant C; Alefantis T; Wigdahl B
Virology; 2003 Mar; 308(1):1-12. PubMed ID: 12706085
[TBL] [Abstract][Full Text] [Related]
18. What we are learning on HTLV-1 pathogenesis from animal models.
Dodon MD; Villaudy J; Gazzolo L; Haines R; Lairmore M
Front Microbiol; 2012; 3():320. PubMed ID: 22969759
[TBL] [Abstract][Full Text] [Related]
19. Early Onset of HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) and Adult T-cell Leukemia/Lymphoma (ATL): Systematic Search and Review.
Oliveira PD; Kachimarek AC; Bittencourt AL
J Trop Pediatr; 2018 Apr; 64(2):151-161. PubMed ID: 28582585
[TBL] [Abstract][Full Text] [Related]
20. Human T-lymphotropic virus 1 (HTLV-1)-associated lichenoid dermatitis induced by CD8+ T cells in HTLV-1 carrier, HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T-cell leukemia/lymphoma.
Tokura Y; Ito T; Kawakami C; Sugita K; Kasuya A; Tatsuno K; Sawada Y; Nakamura M; Shimauchi T
J Dermatol; 2015 Oct; 42(10):967-74. PubMed ID: 26077665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
